BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21735116)

  • 21. Twist predicts poor outcome of patients with astrocytic glioma.
    Nordfors K; Haapasalo J; Mäkelä K; Granberg KJ; Nykter M; Korja M; Paavonen T; Haapasalo H; Soini Y
    J Clin Pathol; 2015 Nov; 68(11):905-12. PubMed ID: 26163539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer.
    Osborne CK; Bardou V; Hopp TA; Chamness GC; Hilsenbeck SG; Fuqua SA; Wong J; Allred DC; Clark GM; Schiff R
    J Natl Cancer Inst; 2003 Mar; 95(5):353-61. PubMed ID: 12618500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.
    Burandt E; Jens G; Holst F; Jänicke F; Müller V; Quaas A; Choschzick M; Wilczak W; Terracciano L; Simon R; Sauter G; Lebeau A
    Breast Cancer Res Treat; 2013 Feb; 137(3):745-53. PubMed ID: 23322234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel estrogen receptor coactivator PELP1/MNAR gene and ERbeta expression in salivary duct adenocarcinoma: potential therapeutic targets.
    Vadlamudi RK; Balasenthil S; Sahin AA; Kies M; Weber RS; Kumar R; El-Naggar AK
    Hum Pathol; 2005 Jun; 36(6):670-5. PubMed ID: 16021574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors.
    Vadlamudi RK; Balasenthil S; Broaddus RR; Gustafsson JA; Kumar R
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6130-8. PubMed ID: 15579769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear karyopherin a2: a novel biomarker for infiltrative astrocytomas.
    Gousias K; Becker AJ; Simon M; Niehusmann P
    J Neurooncol; 2012 Sep; 109(3):545-53. PubMed ID: 22772608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value.
    Rosager AM; Sørensen MD; Dahlrot RH; Hansen S; Schonberg DL; Rich JN; Lathia JD; Kristensen BW
    PLoS One; 2017; 12(8):e0182954. PubMed ID: 28837569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.
    Girault I; Lerebours F; Amarir S; Tozlu S; Tubiana-Hulin M; Lidereau R; Bièche I
    Clin Cancer Res; 2003 Apr; 9(4):1259-66. PubMed ID: 12684393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significantly increased PELP1 protein expression in primary and metastatic triple-negative breast carcinoma: comparison with GATA3 expression and PELP1's potential role in triple-negative breast carcinoma.
    Dang DN; Raj G; Sarode V; Molberg KH; Vadlamudi RK; Peng Y
    Hum Pathol; 2015 Dec; 46(12):1829-35. PubMed ID: 26428280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of vascular adhesion protein-1 is associated with poor prognosis of astrocytomas.
    Kostoro J; Chang SJ; Clark Lai YC; Wu CC; Chai CY; Kwan AL
    APMIS; 2016 Jun; 124(6):462-8. PubMed ID: 26935340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hsp27 and its expression pattern in diffusely infiltrating astrocytomas.
    Mäkelä KS; Haapasalo JA; Ilvesaro JM; Parkkila S; Paavonen T; Haapasalo HK
    Histol Histopathol; 2014 Sep; 29(9):1161-8. PubMed ID: 24599602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis.
    Li L; Li Q; Chen X; Xu M; Li X; Nie L; Chen N; Gong J; Mao Q; Zhou Q
    Neuropathology; 2015 Dec; 35(6):510-7. PubMed ID: 26096696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
    Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
    Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
    Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
    J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome.
    Green AR; Burney C; Granger CJ; Paish EC; El-Sheikh S; Rakha EA; Powe DG; Macmillan RD; Ellis IO; Stylianou E
    Breast Cancer Res Treat; 2008 Aug; 110(3):427-37. PubMed ID: 17902051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Clinical Value of PELP1 for Breast Cancer: A Comparison with Multiple Cancers and Analysis in Breast Cancer Subtypes.
    Wang X; Tsang JYS; Lee MA; Ni YB; Tong JH; Chan SK; Cheung SY; To KF; Tse GM
    Cancer Res Treat; 2019 Apr; 51(2):706-717. PubMed ID: 30134648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomas.
    Campos B; Bermejo JL; Han L; Felsberg J; Ahmadi R; Grabe N; Reifenberger G; Unterberg A; Herold-Mende C
    Cancer Sci; 2011 Feb; 102(2):387-92. PubMed ID: 21143702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression profile and prognostic role of sex hormone receptors in gastric cancer.
    Gan L; He J; Zhang X; Zhang YJ; Yu GZ; Chen Y; Pan J; Wang JJ; Wang X
    BMC Cancer; 2012 Dec; 12():566. PubMed ID: 23199240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.
    Faria MH; Gonçalves BP; do Patrocínio RM; de Moraes-Filho MO; Rabenhorst SH
    Neuropathology; 2006 Dec; 26(6):519-27. PubMed ID: 17203587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis.
    Watanabe Y; Yamasaki F; Kajiwara Y; Saito T; Nishimoto T; Bartholomeusz C; Ueno NT; Sugiyama K; Kurisu K
    J Neurooncol; 2010 Dec; 100(3):449-57. PubMed ID: 20455002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.